LAIR1/CD305[Biotin], His & Avi, Human
LAIR1/CD305[Biotin], His & Avi, Human

Immobilized LAIR1/CD305[Biotin], His & Avi, Human, His Tag at 1 μg/ml (100 μl/Well) on streptavidin(5 μg/ml) precoated plate. Dose response curve for Anti-LAIR1 Antibody, hFc Tag with the EC50 of 4.9ng/ml determined by ELISA.

LAIR1/CD305[Biotin], His & Avi, Human

The purity of LAIR1/CD305[Biotin], His & Avi, Human is greater than 95% as determined by SEC-HPLC.

LAIR1/CD305[Biotin], His & Avi, Human

LAIR1/CD305[Biotin], His & Avi, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

LAIR1/CD305[Biotin], His & Avi, Human

LAIR1 (leukocyte-associated Ig-like receptor-1, designated CD305) is an approximately 40 kDa type I transmembrane inhibitory glycoprotein belonging to the Ig superfamily.LAIR1 functions as an inhibitory receptor that plays a constitutive negative regulatory role on cytolytic function of natural killer (NK) cells, B-cells and T-cells. Activation by Tyr phosphorylation results in recruitment and activation of the phosphatases PTPN6 and PTPN11. It also reduces the increase of intracellular calcium evoked by B-cell receptor ligation.
Z04530
¥123,118.00

Ask us a question
Product Introduction
Species Human
Protein Construction
LAIR1/CD305 (Gln22-His163)
Accession # Q6GTX8-1		 His Avi
N-term C-term
Conjugate Biotin
Purity > 95% as determined by Bis­Tris PAGE 
Endotoxin Level Less than 1EU per μg by the LAL method.
Biological Activity Measured by its binding ability in a functional ELISA. Test result was comparable to standard batch.
Expression System HEK293
Theoretical Molecular Weight 18.2 kDa
Apparent Molecular Weight Due to glycosylation, the protein migrates to 25-35 kDa based on Bis-Tris PAGE result.
Formulation Lyophilized from 0.22μm filtered solution in PBS (pH 7.4).
Reconstitution Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
Storage & Stability Upon receiving, the product remains stable for 6 months at -20℃ or below. Upon reconstitution, the product should be stable for 3 months at -80℃. Avoid repeated freeze-thaw cycles.

Examples
  • LAIR1/CD305[Biotin], His & Avi, Human
    • LAIR1/CD305[Biotin], His & Avi, Human

    Immobilized LAIR1/CD305[Biotin], His & Avi, Human, His Tag at 1 μg/ml (100 μl/Well) on streptavidin(5 μg/ml) precoated plate. Dose response curve for Anti-LAIR1 Antibody, hFc Tag with the EC50 of 4.9ng/ml determined by ELISA.

  • LAIR1/CD305[Biotin], His & Avi, Human
    • LAIR1/CD305[Biotin], His & Avi, Human

    The purity of LAIR1/CD305[Biotin], His & Avi, Human is greater than 95% as determined by SEC-HPLC.

  • LAIR1/CD305[Biotin], His & Avi, Human
    • LAIR1/CD305[Biotin], His & Avi, Human

    LAIR1/CD305[Biotin], His & Avi, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.


Background
Target Background LAIR1 (leukocyte-associated Ig-like receptor-1, designated CD305) is an approximately 40 kDa type I transmembrane inhibitory glycoprotein belonging to the Ig superfamily.LAIR1 functions as an inhibitory receptor that plays a constitutive negative regulatory role on cytolytic function of natural killer (NK) cells, B-cells and T-cells. Activation by Tyr phosphorylation results in recruitment and activation of the phosphatases PTPN6 and PTPN11. It also reduces the increase of intracellular calcium evoked by B-cell receptor ligation.
Synonyms CD305; HLAIR1; LAIR1; LAIR-1

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.